ArticleMolecular neurobiology2025
NLRP3 Inflammasome Activation Contributes to Seizure Susceptibility in Anti-NMDAR Encephalitis: Evidence from Patients and a Mouse Model.
Article in Molecular neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Seizures are common in anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis, yet the mechanisms beyond antibody-mediated NMDAR hypofunction remain poorly understood. This study investigated whether microglial NLRP3 inflammasome activation increases seizure susceptibility and whether its inhibition confers protection. In a pediatric cohort of sixty patients, serum levels of NLRP3 and IL-1β were elevated in patients compared with controls. Multivariable models indicated that NLRP3 was independently associated with seizure presence, whereas IL-1β did not retain independent significance when modeled alongside NLRP3, and model discrimination improved modestly when both markers were included. In an active-immunization mouse model using the GluN1
Indexed as
Identifiers
41217696What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.